MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 592833 | Name: Methylbenzethonium chloride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Methylbenzethonium chloride is an Anti-Infective Agent used in the treatment for American cutaneous leishmaniasis.

Chemical Structure

Methylbenzethonium chloride
Methylbenzethonium chloride
CAS#1320-44-1

Theoretical Analysis

MedKoo Cat#: 592833

Name: Methylbenzethonium chloride

CAS#: 1320-44-1

Chemical Formula: C28H46ClNO3

Exact Mass: 479.3166

Molecular Weight: 480.13

Elemental Analysis: C, 70.05; H, 9.66; Cl, 7.38; N, 2.92; O, 10.00

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Methylbenzethonium chloride
IUPAC/Chemical Name
N-benzyl-N,N-dimethyl-2-(2-(2-methyl-4-(2,4,4-trimethylpentan-2-yl)phenoxy)ethoxy)ethan-1-aminium chloride hydrate
InChi Key
VLYDPWNOCPZGEV-UHFFFAOYSA-M
InChi Code
InChI=1S/C28H44NO2.ClH.H2O/c1-23-20-25(28(5,6)22-27(2,3)4)14-15-26(23)31-19-18-30-17-16-29(7,8)21-24-12-10-9-11-13-24;;/h9-15,20H,16-19,21-22H2,1-8H3;1H;1H2/q+1;;/p-1
SMILES Code
CC(C)(C)CC(C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C(C)=C1)(C)C.[H]O[H].[Cl-]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 480.13 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Livneh A, Youngster I, El-On Y, Berkovitch M, Abu-Kishk I. The lack of effectiveness of hyperbaric oxygenation as a treatment for Leishmania major in a mouse model. Acta Parasitol. 2015 Jun;60(2):345-9. doi: 10.1515/ap-2015-0048. PubMed PMID: 26204005. 2: Wessel F, Winderlich M, Holm M, Frye M, Rivera-Galdos R, Vockel M, Linnepe R, Ipe U, Stadtmann A, Zarbock A, Nottebaum AF, Vestweber D. Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nat Immunol. 2014 Mar;15(3):223-30. doi: 10.1038/ni.2824. Epub 2014 Feb 9. PubMed PMID: 24487320. 3: Siles SA, Srinivasan A, Pierce CG, Lopez-Ribot JL, Ramasubramanian AK. High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors. Antimicrob Agents Chemother. 2013 Aug;57(8):3681-7. doi: 10.1128/AAC.00680-13. Epub 2013 May 20. PubMed PMID: 23689719; PubMed Central PMCID: PMC3719724. 4: Conesa C, Doss MX, Antzelevitch C, Sachinidis A, Sancho J, Carrodeguas JA. Identification of specific pluripotent stem cell death--inducing small molecules by chemical screening. Stem Cell Rev. 2012 Mar;8(1):116-27. doi: 10.1007/s12015-011-9248-4. PubMed PMID: 21617963; PubMed Central PMCID: PMC3305812. 5: McFadden MJ, Junop MS, Brennan JD. Magnetic "fishing" assay to screen small-molecule mixtures for modulators of protein-protein interactions. Anal Chem. 2010 Dec 1;82(23):9850-7. doi: 10.1021/ac102164d. Epub 2010 Nov 10. PubMed PMID: 21067198. 6: González U, Pinart M, Rengifo-Pardo M, Macaya A, Alvar J, Tweed JA. Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004834. doi: 10.1002/14651858.CD004834.pub2. Review. PubMed PMID: 19370612. 7: Kim DH, Chung HJ, Bleys J, Ghohestani RF. Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials. PLoS Negl Trop Dis. 2009;3(2):e381. doi: 10.1371/journal.pntd.0000381. Epub 2009 Feb 17. PubMed PMID: 19221595; PubMed Central PMCID: PMC2637543. 8: González U, Pinart M, Reveiz L, Alvar J. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD005067. doi: 10.1002/14651858.CD005067.pub3. Review. Update in: Cochrane Database Syst Rev. 2017 Nov 17;11:CD005067. PubMed PMID: 18843677. 9: Bailey MS, Lockwood DN. Cutaneous leishmaniasis. Clin Dermatol. 2007 Mar-Apr;25(2):203-11. Review. PubMed PMID: 17350500. 10: El-On J, Bazarsky E, Sneir R. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod. Exp Parasitol. 2007 Jun;116(2):156-62. Epub 2006 Dec 30. PubMed PMID: 17306255. 11: Deng G, Lin DQ, Yao SJ, Mei LH. Aqueous micellar two-phase system composed of hyamine-type hydrophobically modified ethylene oxide and application for cytochrome P450 BM-3 separation. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):167-73. Epub 2007 Jan 13. PubMed PMID: 17287153. 12: Osorio CR, Juiz-Río S, Lemos ML. A siderophore biosynthesis gene cluster from the fish pathogen Photobacterium damselae subsp. piscicida is structurally and functionally related to the Yersinia high-pathogenicity island. Microbiology. 2006 Nov;152(Pt 11):3327-41. PubMed PMID: 17074903. 13: Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop. 2004 Jul;91(2):153-60. PubMed PMID: 15234664. 14: Arana BA, Mendoza CE, Rizzo NR, Kroeger A. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. Am J Trop Med Hyg. 2001 Nov;65(5):466-70. PubMed PMID: 11716099. 15: Kanerva L, Estlander T, Jolanki R. Occupational allergic contact dermatitis from alkylammonium amidobenzoate. Eur J Dermatol. 2001 May-Jun;11(3):240-3. PubMed PMID: 11358732. 16: Krause G, Kroeger A. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study. Clin Infect Dis. 1999 Aug;29(2):466-7. PubMed PMID: 10476776. 17: Grogl M, Schuster BG, Ellis WY, Berman JD. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin. J Parasitol. 1999 Apr;85(2):354-9. PubMed PMID: 10219319. 18: Kotelnikova NE, Panarin EF, Zaikina NA, Kudina NP, Yongfa H, Su LS, Bobasheva AS, Lavrentiev VV. Cellulose materials modified by antiseptics and their antimicrobial properties. Polim Med. 1998;28(3-4):37-53. PubMed PMID: 10093155. 19: Grunwald MH, Amichai B, Trau H. Cutaneous leishmaniasis on an unusual site--the glans penis. Br J Urol. 1998 Dec;82(6):928. PubMed PMID: 9883247. 20: Soto J, Fuya P, Herrera R, Berman J. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. Clin Infect Dis. 1998 Jan;26(1):56-8. PubMed PMID: 9455509.